scholarly journals Monitoring Gene Expression In Vivo with Nucleic Acid Molecular Switches

2005 ◽  
Author(s):  
David C. Ward ◽  
Patricia Bray-Ward
2016 ◽  
Vol 28 (3) ◽  
pp. 278 ◽  
Author(s):  
Su-Jin Cho ◽  
Kyeong-Lim Lee ◽  
Yu-Gon Kim ◽  
Dong-Hoon Kim ◽  
Jae-Gyu Yoo ◽  
...  

We compared the nuclear maturation status and gene-expression profiles of canine cumulus cells (CCs) derived from cumulus–oocyte complexes (COCs) that were spontaneously ovulated versus those that were matured in vitro. Cumulus–oocyte complexes were retrieved from uteri by surgical flushing (after spontaneous ovulation) or by ovariectomy follicle aspiration and in vitro maturation. The objective of Experiment 1 was to investigate the nuclear maturation status of in vivo- versus in vitro-matured oocytes. The objective of Experiment 2 was to compare gene-expression profiles of CCs derived from in vivo- versus in vitro-matured COCs. Genes analysed are related to cell maturation, development and apoptosis, including GDF9, MAPK1, PTX3, CX43, Bcl2 and BAX; mRNA expression for all of these genes, except for GDF9, differed (P < 0.05) between in vivo- and in vitro-matured CCs. In conclusion, we found that gene-expression profiles are related to the quality of CCs and therefore posit that monitoring gene expression could be a useful strategy to guide attempts to improve in vitro culture systems.


2011 ◽  
Vol 57 (4) ◽  
pp. 287-294 ◽  
Author(s):  
Bei Li ◽  
Yafang Tan ◽  
Jingyu Guo ◽  
Baizhong Cui ◽  
Zuyun Wang ◽  
...  

Yersinia pestis is a bacterium that is transmitted between fleas, which have a body temperature of 26 °C, and mammalian hosts, which have a body temperature of 37 °C. To adapt to the temperature shift, phenotype variations, including virulence, occur. In this study, an antigen microarray including 218 proteins of Y. pestis was used to evaluate antibody responses in a pooled plague serum that was unadsorbed, adsorbed by Y. pestis cultivated at 26 °C, or adsorbed by Y. pestis cultivated at 26 and 37 °C to identify protein expression changes during the temperature shift. We identified 12 proteins as being expressed at 37 °C but not at 26 °C, or expressed at significantly higher levels at 37 °C than at 26 °C. The antibodies against 7 proteins in the serum adsorbed by Y. pestis cultivated at 26 and 37 °C remained positive, suggesting that they were not expressed on the surface of Y. pestis in LB broth in vitro or specifically expressed in vivo. This study proved that protein microarray and antibody profiling comprise a promising technique for monitoring gene expression at the protein level and for better understanding pathogenicity, to find new vaccine targets against plague.


2018 ◽  
Vol 11 ◽  
pp. 441-454 ◽  
Author(s):  
Hassan Javanbakht ◽  
Henrik Mueller ◽  
Johanna Walther ◽  
Xue Zhou ◽  
Anaïs Lopez ◽  
...  

2011 ◽  
Vol 30 (4) ◽  
pp. 293-315 ◽  
Author(s):  
Miljen Martić ◽  
Lucile Pernot ◽  
Yvonne Westermaier ◽  
Remo Perozzo ◽  
Tatjana Gazivoda Kraljević ◽  
...  

2010 ◽  
Vol 98 (3) ◽  
pp. 405a
Author(s):  
Konstantinos Lymperopoulos ◽  
Christina Spassova ◽  
Anne Seefeld ◽  
Harendra S. Parekh ◽  
Dirk P. Herten

2021 ◽  
Vol 3 (12) ◽  
Author(s):  
Daniela Araújo ◽  
Dalila Mil-Homens ◽  
Per Trolle Jørgensen ◽  
Arsénio M. Fialho ◽  
Jesper Wengel ◽  
...  

Introduction: Antisense oligonucleotides (ASOs) have been successfully utilized to silence gene expression for the treatment of many genetic human diseases, and particularly the locked nucleic acid (LNA) chemical modification is extensively used with this propose. However, LNA-modified ASOs have never been exploited for controlling virulence genes of Candida. EFG1is an important determinant of virulence that is involved in the switch from yeast to filamentous forms in C. albicans. Thus, our main goal was to explore LNA antisense gapmers for controlling EFG1gene expression and to block C. albicans filamentation. Methods: A set of five LNA-modified gapmers were designed with different chemical modifications (phosphorothioate backbone (PS) and/or palmitoyl-2’-amino-LNA) and ASO length. The in vitro performance of the different ASOs was evaluatedon their ability to control EFG1 gene expression, by qRT-PCR, and to reduce C. albicans’ filamentation, through filaments’ enumeration by microscopy. The in vivo therapeutic potential of ASOs was assessed using a G. mellonella model of infection, through a survival assay. Results: In vitro results showed that all ASOs were able to reduce the levels of EFG1gene expression, consequently reducing the levels of C. albicans filamentation around 50%. Interestingly, in vivo tests showed that the LNA-modified gapmer with PS backbone and palmitoyl-2’-amino-LNA was more effective at preventing G. mellonella infections. Conclusions: Undeniably, this work promotes the development of a novel approach for the treatment of Candida infections based on the delivery of ASOs coupled with LNA chemical modification.


Sign in / Sign up

Export Citation Format

Share Document